Related Experiment Videos
Monocyte C1-inhibitor synthesis in patients with C1-inhibitor deficiency
D F Lappin1, A R McPhaden, P L Yap
1University of Glasgow Pathology Department, Western Infirmary, Scotland, U.K.
Insights
Patients with type 1 hereditary angioedema (HAE) show reduced C1-inhibitor (C1-inh) production due to lower C1-inh gene expression. Gamma-interferon can stimulate C1-inh production and mRNA levels in these patients.
Area of Science:
- Immunology
- Genetics
- Molecular Biology
Background:
- Hereditary angioedema (HAE) is a rare genetic disorder characterized by recurrent swelling attacks.
- C1-inhibitor (C1-inh) deficiency is a primary cause of HAE, affecting complement system regulation.
- Understanding the molecular basis of C1-inh deficiency is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the molecular mechanisms underlying C1-inhibitor (C1-inh) deficiency in different types of HAE.
- To assess the role of C1-inh gene expression and the potential of gamma-interferon as a therapeutic agent.
Main Methods:
- Monocyte isolation from HAE patients (type 1, type 2, acquired) and healthy controls.
- Quantification of C1-inhibitor (C1-inh) protein production.
- Measurement of C1-inh messenger ribonucleic acid (mRNA) levels.
- Stimulation of monocytes with recombinant gamma-interferon.
Main Results:
- Monocytes from most type 1 HAE patients produced significantly less C1-inh (40%) and had lower C1-inh mRNA levels compared to controls.
- Type 2 and acquired C1-inh deficiency showed normal C1-inh production.
- Gamma-interferon significantly increased C1-inh production and mRNA levels in both controls and type 1 HAE patients.
- One type 1 HAE patient with undetectable basal C1-inh levels showed restored production upon gamma-interferon stimulation.
Conclusions:
- Type 1 HAE is associated with reduced C1-inh gene transcription.
- Gamma-interferon demonstrates potential in enhancing C1-inh production and mRNA levels, suggesting a therapeutic avenue for HAE.
- A potential genetic lesion in type 2 HAE patients may involve single-allele transcription.
Abstract:
Monocytes of seven out of eight patients with type 1 C1-inhibitor (C1-inh) deficiency (HAE) produced 40% as much C1-inh as monocytes from normal donors (controls). In contrast, monocytes from three patients with type 2 and three patients with acquired C1-inh deficiency produced similar amounts of C1-inh as controls. Recombinant gamma-interferon (gamma-interferon 10 ng/ml) stimulated C1-inh production of C1-inh (eight-10-fold) by control and patients' monocytes. Monocytes from patients with type 1 HAE contained 40% the level of C1-inh messenger ribonucleic acid (mRNA) found in control monocytes. Gamma-interferon increased the abundance of C1-inh mRNA by the same extent in both control and patients' monocytes. C1-inh protein and mRNA were undetectable in the monocytes of one patient, unless stimulated by gamma-interferon. Under these conditions, his monocytes produced comparable amounts of C1-inh (protein and mRNA) as gamma-interferon-stimulated monocytes of the other type 1 HAE patients. The data suggest that in most type 2 HAE patients there is a lesion in the C1-inh gene such that mRNA is transcribed by a single allele.